|
1
|
Brooks L, Yao QY, Rickinson AB and Young
LS: Epstein-Barr virus latent gene transcription in nasopharyngeal
carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.
J Virol. 66:2689–2697. 1992.PubMed/NCBI
|
|
2
|
Thompson MP and Kurzrock R: Epstein-Barr
virus and cancer. Clin Cancer Res. 10:803–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang M, Zong YS, He JH, Lin SX, Zhong BL
and Liang YJ: Comparison of Epstein-Barr virus infection and 30
bp-deleted LMP1 gene among four histological types of
nasopharyngeal carcinoma. Chin Med J. 117:608–611. 2004.PubMed/NCBI
|
|
4
|
Tao Q, Young LS, Woodman CB and Murray PG:
Epstein-Barr virus (EBV) and its associated human cancers -
genetics, epigenetics, pathobiology and novel therapeutics. Front
Biosci. 11:2672–2713. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zheng H, Li LL, Hu DS, Deng XY and Cao Y:
Role of Epstein-Barr virus encoded latent membrane protein 1 in the
carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol.
4:185–196. 2007.PubMed/NCBI
|
|
6
|
Akiba H, Nakano H, Nishinaka S, et al:
CD27, a member of the tumor necrosis factor receptor superfamily,
activates NF-kappaB and stress-activated protein kinase/c-Jun
N-terminal kinase via TRAF2, TRAF5, and NF-kappaB-inducing kinase.
J Biol Chem. 273:13353–13358. 1998. View Article : Google Scholar
|
|
7
|
Deng L, Yang J, Zhao XR, et al: Cells in
G2/M phase increased in human nasopharyngeal carcinoma cell line by
EBV-LMP1 through activation of NF-kappaB and AP-1. Cell Res.
13:187–194. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thornburg NJ, Kulwichit W, Edwards RH,
Shair KH, Bendt KM and Raab-Traub N: LMP1 signaling and activation
of NF-kappaB in LMP1 transgenic mice. Oncogene. 25:288–297.
2006.PubMed/NCBI
|
|
9
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.PubMed/NCBI
|
|
10
|
Shao JY, Huang XM, Yu XJ, et al: Loss of
heterozygosity and its correlation with clinical outcome and
Epstein-Barr virus infection in nasopharyngeal carcinoma.
Anticancer Res. 21:3021–3029. 2001.PubMed/NCBI
|
|
11
|
Gao J, Luo X, Tang K, Li X and Li G:
Epstein-Barr virus integrates frequently into chromosome 4q, 2q, 1q
and 7q of Burkitt’s lymphoma cell line (Raji). J Virol Methods.
136:193–199. 2006.PubMed/NCBI
|
|
12
|
Bandres E, Cubedo E, Agirre X, et al:
Identification by Real-time PCR of 13 mature microRNAs
differentially expressed in colorectal cancer and non-tumoral
tissues. Mol Cancer. 5:292006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Calin GA, Sevignani C, Dumitru CD, et al:
Human microRNA genes are frequently located at fragile sites and
genomic regions involved in cancers. Proc Natl Acad Sci USA.
101:2999–3004. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang X, Tang S, Le SY, et al: Aberrant
expression of oncogenic and tumor-suppressive microRNAs in cervical
cancer is required for cancer cell growth. PLoS One. 3:e25572008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hurst DR, Edmonds MD, Scott GK, Benz CC,
Vaidya KS and Welch DR: Breast cancer metastasis suppressor 1
up-regulates miR-146, which suppresses breast cancer metastasis.
Cancer Res. 69:1279–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Taganov KD, Boldin MP, Chang KJ and
Baltimore D: NF-kappaB-dependent induction of microRNA miR-146, an
inhibitor targeted to signaling proteins of innate immune
responses. Proc Natl Acad Sci USA. 103:12481–12486. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Luo X, Yang W, Ye DQ, et al: A functional
variant in microRNA-146a promoter modulates its expression and
confers disease risk for systemic lupus erythematosus. PLoS Genet.
7:e10021282011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
He H, Jazdzewski K, Li W, et al: The role
of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad
Sci USA. 102:19075–19080. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Motsch N, Pfuhl T, Mrazek J, Barth S and
Grasser FA: Epstein-Barr virus-encoded latent membrane protein 1
(LMP1) induces the expression of the cellular microRNA miR-146a.
RNA Biol. 4:131–137. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cameron JE, Yin Q, Fewell C, et al:
Epstein-Barr virus latent membrane protein 1 induces cellular
MicroRNA miR-146a, a modulator of lymphocyte signaling pathways. J
Virol. 82:1946–1958. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jazdzewski K, Murray EL, Franssila K,
Jarzab B, Schoenberg DR and de la Chapelle A: Common SNP in
pre-miR-146a decreases mature miR expression and predisposes to
papillary thyroid carcinoma. Proc Natl Acad Sci USA. 105:7269–7274.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xu T, Zhu Y, Wei QK, et al: A functional
polymorphism in the miR-146a gene is associated with the risk for
hepatocellular carcinoma. Carcinogenesis. 29:2126–2131. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang H, Luo XQ, Zhang P, et al: MicroRNA
patterns associated with clinical prognostic parameters and CNS
relapse prediction in pediatric acute leukemia. PLoS One.
4:e78262009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Couturier JP and Root-Bernstein RS: HIV
may produce inhibitory microRNAs (miRNAs) that block production of
CD28, CD4 and some interleukins. J Theor Biol. 235:169–184. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sullivan CS, Grundhoff AT, Tevethia S,
Pipas JM and Ganem D: SV40-encoded microRNAs regulate viral gene
expression and reduce susceptibility to cytotoxic T cells. Nature.
435:682–686. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gupta A, Gartner JJ, Sethupathy P,
Hatzigeorgiou AG and Fraser NW: Anti-apoptotic function of a
microRNA encoded by the HSV-1 latency-associated transcript.
Nature. 442:82–85. 2006.PubMed/NCBI
|
|
29
|
Rana TM: Illuminating the silence:
understanding the structure and function of small RNAs. Nat Rev Mol
Cell Biol. 8:23–36. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen Y and Chen XY: Effect of Epstein-Barr
virus latent membrane protein 1 (LMP1) on apoptosis of
nasopharyngeal carcinoma cell line CNE1. Ai Zheng. 21:498–503.
2002.(In Chinese).
|
|
31
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
|
|
32
|
Henderson A, Ripley S, Heller M and Kieff
E: Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor
cell line and in lymphocytes growth-transformed in vitro. Proc Natl
Acad Sci USA. 80:1987–1991. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kieser A, Kilger E, Gires O, Ueffing M,
Kolch W and Hammerschmidt W: Epstein-Barr virus latent membrane
protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase
cascade. EMBO J. 16:6478–6485. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gires O, Kohlhuber F, Kilger E, et al:
Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3
and activates STAT proteins. EMBO J. 18:3064–3073. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Everly DN Jr, Mainou BA and Raab-Traub N:
Induction of Id1 and Id3 by latent membrane protein 1 of
Epstein-Barr virus and regulation of p27/Kip and cyclin-dependent
kinase 2 in rodent fibroblast transformation. J Virol.
78:13470–13478. 2004. View Article : Google Scholar
|
|
36
|
Li HM, Zhuang ZH, Wang Q, et al:
Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1
expression in nasopharyngeal epithelial cells. Oncogene.
23:4488–4494. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hau PM, Tsang CM, Yip YL, Huen MS and Tsao
SW: Id1 interacts and stabilizes the Epstein-Barr virus latent
membrane protein 1 (LMP1) in nasopharyngeal epithelial cells. PLoS
One. 6:e211762011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Talaty P, Emery A and Everly DN Jr:
Characterization of the latent membrane protein 1 signaling complex
of Epstein-Barr virus in the membrane of mammalian cells with
bimolecular fluorescence complementation. Virol J. 8:4142011.
View Article : Google Scholar
|
